Literature DB >> 22048068

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.

Maria G Cersosimo1, Eduardo E Benarroch.   

Abstract

Gastrointestinal dysfunction is a prominent manifestation of Parkinson's disease (PD). Gastrointestinal symptoms in PD include reduced salivation, dysphagia, impaired gastric emptying, constipation, and defecatory dysfunction. Constipation may precede the development of somatic motor symptoms of PD for several years. Neuropathological studies show early accumulation of abnormal alpha-synuclein (α-SYN) containing inclusions (Lewy neurites) in the enteric nervous system (ENS) and dorsal motor nucleus of the vagus (DMV) both in PD and in incidental Lewy body disease (ILBD). These findings provided the basis for the hypothesis that α-SYN pathology progresses in a centripetal, prion-like fashion, from the ENS to the DMV and then to more rostral areas of the central nervous system. Colonic biopsies may show accumulation α-SYN immunoreactive Lewy neurites in the submucosal plexus of PD patients. Salivary gland involvement is prominent in PD and α-SYN pathology can be detected both at autopsy and in minor salivary gland biopsies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22048068     DOI: 10.1016/j.nbd.2011.10.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  88 in total

Review 1.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

2.  Involvement of catecholaminergic neurons in motor innervation of striated muscle in the mouse esophagus.

Authors:  Piet van der Keylen; Fabian Garreis; Ruth Steigleder; Daniel Sommer; Winfried L Neuhuber; Jürgen Wörl
Journal:  Histochem Cell Biol       Date:  2016-01-21       Impact factor: 4.304

Review 3.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Michal Lubomski; Ryan L Davis; Carolyn M Sue
Journal:  J Neurol       Date:  2020-01-27       Impact factor: 4.849

5.  Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.

Authors:  Anastasia Bougea; Christos Koros; Leonidas Stefanis
Journal:  J Neural Transm (Vienna)       Date:  2019-08-10       Impact factor: 3.575

6.  Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.

Authors:  Cecilia Bove; Laura Anselmi; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-05-01       Impact factor: 4.052

7.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

8.  Vagally mediated effects of brain stem dopamine on gastric tone and phasic contractions of the rat.

Authors:  L Anselmi; L Toti; C Bove; R A Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-20       Impact factor: 4.052

9.  Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

Authors:  Shinji Ito; Masaki Takao; Hiroyuki Hatsuta; Kazutomi Kanemaru; Tomio Arai; Yuko Saito; Masashi Fukayama; Shigeo Murayama
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

10.  Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in rats.

Authors:  Qunhua Bai; Junlin He; Yong Tang; Shibo Wang; Jingfu Qiu; Yang Wang; Chao Yu
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.